Shares of Jubilant Life Sciences today advanced by 7.5 per cent after the company posted 22.48 per cent rise in consolidated net profit for the first quarter ended June 30, 2016-17.
The scrip soared 7.43 per cent to settle at Rs 367.30 on BSE. Intra-day, it jumped 11.37 per cent to Rs 380.80.
On NSE, the stock gained 7.49 per cent to close at Rs 367.95.
The company's market valuation went up by Rs 405.4 crore, to Rs 5,850.40 crore.
Jubilant yesterday posted 22.48 per cent rise in consolidated net profit at Rs 161.60 crore for the first quarter ended June 30, on robust sales in the pharmaceuticals segment.
The company had posted a net profit of Rs 131.93 crore for the same period of the previous fiscal.
Net sales of the company also rose to Rs 1,425.53 crore during the first quarter as against Rs 1,400.97 crore in the same period of the last financial year, Jubilant Life Sciences had said in a statement.
